Component
Solubilized-sludge fulvic fraction, 2011 study
Context-specific entity; species, compartment and exposure are stated on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
SS-FA pretreatment altered allergy-associated transcripts in stimulated KU812 cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human KU812 microarray study following PMA/calcium-ionophore stimulation.
- limitations
- Expression changes are not proof of direct receptor binding; cell-line results do not establish an oral dose.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- The cell response included changes in gene expression.
- primary_references
- Microarray analysis of immediate-type allergy in KU812 cells in response to fulvic acid. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21331654/ · DOI 10.1007/s10616-010-9333-6
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 116–122
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human KU812 microarray study following PMA/calcium-ionophore stimulation. · source_derived_draft · unverified_draft
## fulvic-acid-allergy-transcript The cell response included changes in gene expression. SS-FA pretreatment altered allergy-associated transcripts in stimulated KU812 cells. Model: Human KU812 microarray study following PMA/calcium-ionophore stimulation. Limitations: Expression changes are not proof of direct receptor binding; cell-line results do not establish an oral dose. Evidence access: Primary abstract Microarray analysis of immediate-type allergy in KU812 cells in response to fulvic acid. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21331654/ · DOI 10.1007/s10616-010-9333-6
Complete structured claim and evidenceSS-FA at 0.1-10 micrograms/mL reduced PMA/calcium-ionophore-induced histamine release from KU812 cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human basophilic leukemia KU812 cells; 15-minute pretreatment, PMA 20 nM plus A23187 1 micromolar.
- limitations
- Sludge-derived research material is not a dietary ingredient recommendation. This does not establish human allergy treatment or direct calcium chelation.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- One preparation reduced triggered mediator release.
- primary_references
- Microarray analysis of immediate-type allergy in KU812 cells in response to fulvic acid. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21331654/ · DOI 10.1007/s10616-010-9333-6
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 108–114
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human basophilic leukemia KU812 cells; 15-minute pretreatment, PMA 20 nM plus A23187 1 micromolar. · source_derived_draft · unverified_draft
## fulvic-acid-histamine One preparation reduced triggered mediator release. SS-FA at 0.1-10 micrograms/mL reduced PMA/calcium-ionophore-induced histamine release from KU812 cells. Model: Human basophilic leukemia KU812 cells; 15-minute pretreatment, PMA 20 nM plus A23187 1 micromolar. Limitations: Sludge-derived research material is not a dietary ingredient recommendation. This does not establish human allergy treatment or direct calcium chelation. Evidence access: Primary abstract Microarray analysis of immediate-type allergy in KU812 cells in response to fulvic acid. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21331654/ · DOI 10.1007/s10616-010-9333-6
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.